Art

J-GLOBAL ID：201502213166793630   Reference number：15A1380596

Enhanced dipicolinic acid production during the stationary phase in Bacillus subtilis by blocking acetoin synthesis

枯草菌Bacillus subtilisの定常期間中のアセトイン合成の阻害によるジピコリン酸生産の増強

Author (23)： TOYA Yoshihiro (Osaka Univ., Suita, JPN) ,  TOYA Yoshihiro (JST-ALCA, JPN) ,  HIRASAWA Takashi (Osaka Univ., Suita, JPN) ,  HIRASAWA Takashi (JST-ALCA, JPN) ,  HIRASAWA Takashi (Tokyo Inst. of Technol., Yokohama, JPN) ,  ISHIKAWA Shu (JST-ALCA, JPN) ,  ISHIKAWA Shu (Nara Inst. of Sci. and Technol., Ikoma, JPN) ,  CHUMSAKUL Onuma (JST-ALCA, JPN) ,  CHUMSAKUL Onuma (Nara Inst. of Sci. and Technol., Ikoma, JPN) ,  MORIMOTO Takuya (JST-ALCA, JPN) ,  MORIMOTO Takuya (Kao Corp., Haga, JPN) ,  LIU Shenghao (JST-ALCA, JPN) ,  LIU Shenghao (Kao Corp., Haga, JPN) ,  MASUDA Kenta (JST-ALCA, JPN) ,  MASUDA Kenta (Kao Corp., Haga, JPN) ,  KAGEYAMA Yasushi (JST-ALCA, JPN) ,  KAGEYAMA Yasushi (Kao Corp., Haga, JPN) ,  OZAKI Katsuya (JST-ALCA, JPN) ,  OZAKI Katsuya (Kao Corp., Haga, JPN) ,  OGASAWARA Naotake (JST-ALCA, JPN) ,  OGASAWARA Naotake (Nara Inst. of Sci. and Technol., Ikoma, JPN) ,  SHIMIZU Hiroshi (Osaka Univ., Suita, JPN) ,  SHIMIZU Hiroshi (JST-ALCA, JPN)
Material： Bioscience, Biotechnology, and Biochemistry  (Bioscience Biotechnology & Biochemistry)
Volume： 79  Issue： 12  Page： 2073-2080  Publication year： Dec. 2015 
JST Material Number： G0021A  ISSN： 0916-8451  CODEN： BBBIEJ  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： inhibition ,...
Semi thesaurus term： alsSD ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1380596&from=J-GLOBAL&jstjournalNo=G0021A") }}

JST classification (3)： Microbial metabolite production  (FK03020A) ,  Metabolism and nutrition  (EG03054K) ,  Gene manipulation  (EC02050B)

Substance index (4)： Acetyl Coenzyme A ,  Acetoin ,  Dipicolinic acid ,  Pyruvic Acid

Reference (20)：

• Westers L, Westers H, Quax WJ. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta. 2004;1694: 299-310.
• Perkins JB, Sloma A, Hermann T, et al. Genetic engineering of Bacillus subtilis for the commercial production of riboflavin. J. Ind. Microbiol. Biotechnol. 1999;22:8-18.
• Jia X, Li S, Xie S, Wen J. Engineering a metabolic pathway for isobutanol biosynthesis in Bacillus subtilis. Appl. Biochem. Biotechnol. 2012;168:1-9.
• Biswas R, Yamaoka M, Nakayama H, et al. Enhanced production of 2,3-butanediol by engineered Bacillus subtilis. Appl. Microbiol. Biotechnol. 2012;94:651-658.
• Wang M, Fu J, Zhang X, Chen T. Metabolic engineering of Bacillus subtilis for enhanced production of acetoin. Biotechnol. Lett. 2012;34,1877-1885.

Terms in the title (6)： 枯草菌 ,  Bacillus ,  アセトイン ,  阻害 ,  ジピコリン酸 ,  増強